/PRNewswire/ NYU Langone Health is joining a new National Institutes of Health (NIH)-sponsored program called Accelerating Medicines Partnership Autoimmune.
NYU Langone joins NIH-sponsored program called Accelerating Medicines Partnership Autoimmune and Immune-Mediated Diseases to find new therapies. Learn more.
NYU Langone Health is joining a new National Institutes of Health (NIH)-sponsored program called Accelerating Medicines Partnership Autoimmune and Immune-Mediated Diseases (AMP AIM) as a leading center to discover new targets for therapy in these diseases.